Percutaneous dilatational tracheotomy in high-risk ICU patients.

Airway management Anticoagulation Bleeding Dual antiplatelet therapy Percutaneous dilatational tracheotomy

Journal

Annals of intensive care
ISSN: 2110-5820
Titre abrégé: Ann Intensive Care
Pays: Germany
ID NLM: 101562873

Informations de publication

Date de publication:
28 Jul 2021
Historique:
received: 09 05 2021
accepted: 10 07 2021
entrez: 28 7 2021
pubmed: 29 7 2021
medline: 29 7 2021
Statut: epublish

Résumé

Percutaneous dilatational tracheotomy (PDT) has become an established procedure in intensive care units (ICU). However, the safety of this method has been under debate given the growing number of critically ill patients with high bleeding risk receiving anticoagulation, dual antiplatelet therapy (DAPT) or even a combination of both, i.e. triple therapy. Therefore, the purpose of this study, including such a high proportion of patients on antithrombotic therapy, was to investigate whether PDT in high-risk ICU patients is associated with elevated procedural complications and to analyse the risk factors for bleeding occurring during and after PDT. PDT interventions conducted in ICUs at 12 European sites between January 2016 and October 2019 were retrospectively analysed for procedural complications. For subgroup analyses, patient stratification into clinically relevant risk groups based on anticoagulation and antiplatelet treatment regimens was performed and the predictors of bleeding occurrence were analysed. In total, 671 patients receiving PDT were included and stratified into four clinically relevant antithrombotic treatment groups: (1) intravenous unfractionated heparin (iUFH, prophylactic dosage) (n = 101); (2) iUFH (therapeutic dosage) (n = 131); (3) antiplatelet therapy (aspirin and/or P2Y In this international, multicenter study bronchoscopy-guided PDT was a safe and low-complication airway management option, even in a cohort of high risk for bleeding on cardiovascular ICUs. Low platelet count, chronic kidney disease and previous stroke were identified as independent risk factors of bleeding during and after PDT but not triple therapy.

Sections du résumé

BACKGROUND BACKGROUND
Percutaneous dilatational tracheotomy (PDT) has become an established procedure in intensive care units (ICU). However, the safety of this method has been under debate given the growing number of critically ill patients with high bleeding risk receiving anticoagulation, dual antiplatelet therapy (DAPT) or even a combination of both, i.e. triple therapy. Therefore, the purpose of this study, including such a high proportion of patients on antithrombotic therapy, was to investigate whether PDT in high-risk ICU patients is associated with elevated procedural complications and to analyse the risk factors for bleeding occurring during and after PDT.
METHODS METHODS
PDT interventions conducted in ICUs at 12 European sites between January 2016 and October 2019 were retrospectively analysed for procedural complications. For subgroup analyses, patient stratification into clinically relevant risk groups based on anticoagulation and antiplatelet treatment regimens was performed and the predictors of bleeding occurrence were analysed.
RESULTS RESULTS
In total, 671 patients receiving PDT were included and stratified into four clinically relevant antithrombotic treatment groups: (1) intravenous unfractionated heparin (iUFH, prophylactic dosage) (n = 101); (2) iUFH (therapeutic dosage) (n = 131); (3) antiplatelet therapy (aspirin and/or P2Y
CONCLUSION CONCLUSIONS
In this international, multicenter study bronchoscopy-guided PDT was a safe and low-complication airway management option, even in a cohort of high risk for bleeding on cardiovascular ICUs. Low platelet count, chronic kidney disease and previous stroke were identified as independent risk factors of bleeding during and after PDT but not triple therapy.

Identifiants

pubmed: 34319491
doi: 10.1186/s13613-021-00906-5
pii: 10.1186/s13613-021-00906-5
pmc: PMC8319261
doi:

Types de publication

Journal Article

Langues

eng

Pagination

116

Investigateurs

Stefan Kääb (S)
Stefan Brunner (S)
Mathias Orban (M)
Tobias Petzold (T)
Saliha Kehar (S)
Sara Würbel (S)
Hans-Joachim Stemmler (HJ)
Leonhard Binzenhöfer (L)
Jan Kleeberger (J)
Antonia Kellnar (A)

Informations de copyright

© 2021. The Author(s).

Références

Crit Care Med. 2005 Nov;33(11):2527-33
pubmed: 16276177
Crit Care Med. 1991 Aug;19(8):1018-24
pubmed: 1860325
Br J Anaesth. 2015 Mar;114(3):396-405
pubmed: 25534400
Crit Care Med. 2005 May;33(5):1015-20
pubmed: 15891330
Crit Care Med. 2005 Feb;33(2):290-8
pubmed: 15699830
Laryngoscope. 2016 Nov;126(11):2459-2467
pubmed: 27075530
Crit Care. 2014 Dec 19;18(6):544
pubmed: 25526983
Laryngoscope. 2005 Oct;115(10 Pt 2):1-30
pubmed: 16227862
BMJ. 2005 May 28;330(7502):1243
pubmed: 15901643
Eur J Anaesthesiol. 2010 Aug;27(8):676-82
pubmed: 20523214
Intensive Care Med. 2019 Nov;45(11):1619-1621
pubmed: 31451858
Am J Respir Crit Care Med. 1999 Feb;159(2):383-8
pubmed: 9927347
Crit Care Resusc. 2009 Dec;11(4):244-9
pubmed: 20001871
Chest. 2000 Nov;118(5):1412-8
pubmed: 11083694
Chest. 2011 Feb;139(2):271-278
pubmed: 21071526
Lancet Respir Med. 2015 Feb;3(2):150-158
pubmed: 25680911
Acta Anaesthesiol Scand. 2011 Aug;55(7):835-41
pubmed: 21615346
Crit Care Explor. 2019 Oct 30;1(10):e0050
pubmed: 32166231
Acta Anaesthesiol Scand. 2006 Jan;50(1):92-8
pubmed: 16451156
Laryngorhinootologie. 2016 Jan;95(1):29-36
pubmed: 26458036
Acta Anaesthesiol Scand. 1998 May;42(5):545-50
pubmed: 9605370
Crit Care. 2006;10(2):R55
pubmed: 16606435
Crit Care Med. 2004 Aug;32(8):1689-94
pubmed: 15286545
JACC Cardiovasc Interv. 2019 Aug 26;12(16):1521-1537
pubmed: 31202949
Thorac Cardiovasc Surg. 2013 Apr;61(3):234-9
pubmed: 23344764
JAMA. 2013 May 22;309(20):2121-9
pubmed: 23695482
Anaesthesist. 2005 Sep;54(9):929-41, quiz 942-3
pubmed: 16091924
Eur J Cardiothorac Surg. 2007 Sep;32(3):412-21
pubmed: 17588767
Langenbecks Arch Surg. 2018 Mar;403(2):137-149
pubmed: 29282535
Stroke. 2013 Jan;44(1):21-8
pubmed: 23204058
Pneumologie. 2014 May;68(5):322-8
pubmed: 24658895
Ann Intensive Care. 2018 Mar 15;8(1):37
pubmed: 29546588
Chest. 1985 Jun;87(6):715-9
pubmed: 3996056

Auteurs

Enzo Lüsebrink (E)

Intensive Care Unit, Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Marchioninistraße 15, 81377, Munich, Germany.
DZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Munich, Germany.

Alexander Krogmann (A)

Medizinische Klinik und Poliklinik II, Universitätsklinikum Bonn, Bonn, Germany.

Franziska Tietz (F)

Heart Center Leipzig at University of Leipzig, Department of Internal Medicine/Cardiology and Leipzig Heart Institute, Leipzig, Germany.

Matthias Riebisch (M)

Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, Essen, Germany.

Rainer Okrojek (R)

Medizinische Klinik und Poliklinik I, Klinikum Rechts der Isar der Technischen Universität München, Munich, Germany.

Friedhelm Peltz (F)

Medizinische Klinik und Poliklinik I, Klinikum Rechts der Isar der Technischen Universität München, Munich, Germany.

Carsten Skurk (C)

Klinik Für Kardiologie, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin, Berlin, Germany.

Carsten Hullermann (C)

Klinik Für Kardiologie I: Koronare Herzkrankheit, Herzinsuffizienz und Angiologie, Universitätsklinikum Münster, Münster, Germany.

Jan Sackarnd (J)

Klinik Für Kardiologie I: Koronare Herzkrankheit, Herzinsuffizienz und Angiologie, Universitätsklinikum Münster, Münster, Germany.

Dietmar Wassilowsky (D)

Klinik Für Anästhesiologie, Klinikum der Universität München, Munich, Germany.

Karl Toischer (K)

Klinik Für Kardiologie, Angiologie und Pneumologie, Herzzentrum Göttingen, Göttingen, Germany.

Clemens Scherer (C)

Intensive Care Unit, Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Marchioninistraße 15, 81377, Munich, Germany.
DZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Munich, Germany.

Michael Preusch (M)

Klinik Für Kardiologie, Angiologie und Pneumologie, Universitätsklinikums Heidelberg, Heidelberg, Germany.

Christoph Testori (C)

Landesklinikum Wiener Neustadt, Wien, Österreich.

Ulrike Flierl (U)

Klinik Für Kardiologie und Angiologie, Medizinische Hochschule Hannover, Hannover, Germany.

Sven Peterss (S)

Herzchirurgische Klinik und Poliklinik, Klinikum der Universität München, Munich, Germany.

Sabine Hoffmann (S)

Institut Für Medizinische Informationsverarbeitung Biometrie und Epidemiologie, Klinikum der Universität München, Munich, Germany.

Nikolaus Kneidinger (N)

Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Munich, Germany.
German Center for Lung Research (DZL), Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Munich, Germany.

Christian Hagl (C)

Herzchirurgische Klinik und Poliklinik, Klinikum der Universität München, Munich, Germany.

Steffen Massberg (S)

Intensive Care Unit, Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Marchioninistraße 15, 81377, Munich, Germany.
DZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Munich, Germany.

Sebastian Zimmer (S)

Medizinische Klinik und Poliklinik II, Universitätsklinikum Bonn, Bonn, Germany.

Peter Luedike (P)

Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, Essen, Germany.

Tienush Rassaf (T)

Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, Essen, Germany.

Holger Thiele (H)

Heart Center Leipzig at University of Leipzig, Department of Internal Medicine/Cardiology and Leipzig Heart Institute, Leipzig, Germany.

Andreas Schäfer (A)

Klinik Für Kardiologie und Angiologie, Medizinische Hochschule Hannover, Hannover, Germany.

Martin Orban (M)

Intensive Care Unit, Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Marchioninistraße 15, 81377, Munich, Germany. MartinOrban@gmail.com.
DZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Munich, Germany. MartinOrban@gmail.com.

Classifications MeSH